Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 583 filings
- On EDGAR
- CIK 1626971
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 45
News 8 of 126
Prospectuses and Registrations 8 of 33
- S-8 Registration statement for an employee plan May 7, 2026
- 424B5 Prospectus supplement for an offering Mar 13, 2026
- S-3ASR Automatic shelf registration Mar 13, 2026
- 424B5 Prospectus supplement for an offering Jan 23, 2026
- 424B5 Prospectus supplement for an offering Jan 20, 2026
- S-8 Registration statement for an employee plan May 8, 2025
- S-3 Shelf registration statement Aug 6, 2024
- S-8 Registration statement for an employee plan May 7, 2024
Proxies 8 of 21
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 325
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 27, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade May 20, 2026
Other 8 of 33
- S-3MEF Jan 21, 2026
- EFFECT Notice that a registration became effective Aug 15, 2024
- CORRESP Reply to SEC staff Aug 13, 2024
- UPLOAD Comment letter from SEC staff Aug 13, 2024
- EFFECT Notice that a registration became effective May 8, 2023
- CORRESP Reply to SEC staff May 4, 2023
- UPLOAD Comment letter from SEC staff Mar 31, 2023
- SEC STAFF LETTER Mar 29, 2021
Everything here comes from Corvus Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.